Syncona Appoints Investment Banker Melanie Gee As Chair Designate

LONDON (Alliance News) - Healthcare company Syncona Ltd on Tuesday said Melanie Gee will take over the chair of its board from Jeremy Tigue over the coming months in preparation for Tigue's retirement at end of 2019.

Gee has been appointed as non-executive director and chair-designate with immediate effect. She has over 30 years' experience in the financial advisory industry and currently is a non-executive director of Standard Life Aberdeen PLC and senior advisor for Lazard & Co Ltd.

"We are very pleased to announce the appointment of Melanie to the board of Syncona Ltd and as chair-designate today as part of our board succession planning process. Melanie will be a strong addition to our board, and we look forward to working with her to continue our strategy of investing in exceptional science whilst striving to deliver transformational treatments to patients," said Senior Independent Director Nicholas Moss.

Shares in Syncona were down 0.4% at 230.00 pence each on Tuesday morning.

Syncona